InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the complete record of transactions filed by DOYLE WILLIAM F, Président Exécutif. Insider active across 2 companies, notably NovoCure Ltd. Aggregated, 5 disclosures have been logged. Total volume traded: €404k. The latest transaction was disclosed on 8 March 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
€153,8742,385 shares@ €64.51720.011% mcap38.1% of flow
Ordinary Shares
SEC:0001645113-22-000024:0·
07,307 shares0
Common Stock
SEC:0001179110-21-010527·
07,307 shares0
Common Stock
SEC:0001179110-21-010527:0·
€125,167995 shares@ €125.79570.0086% mcap100.0% of flow
Ordinary Shares
SEC:0001645113-21-000096·
€125,167995 shares@ €125.79570.0086% mcap31.0% of flow
Ordinary Shares
SEC:0001645113-21-000096:0·
5 of 5 declarations
About DOYLE WILLIAM F
William F. Doyle is the Executive Chairman and Director at NovoCure Ltd and Elanco Animal Health Inc. In this role, he oversees board activities and contributes to the strategic direction of the companies. Doyle brings significant experience in leadership and management, helping to guide growth initiatives and ensure regulatory compliance. His commitment to operational excellence is an asset to the board.
